SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
Syncope is a common reason for emergency department (ED) presentation. While often benign, some patients have serious and life-threatening underlying causes, both cardiac and non-cardiac, which may or may not be apparent at the time of the initial ED assessment. Identifying which patients will benefit from further inve
| Condition(s) | Syncope |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Syncope is a common reason for emergency department (ED) presentation. While often benign, some patients have serious and life-threatening underlying causes, both cardiac and non-cardiac, which may or may not be apparent at the time of the initial ED assessment. Identifying which patients will benefit from further investigation, ongoing monitoring and/or hospital admission is essential to reduce both adverse outcomes and high costs. The research team has spent over a decade developing the evidence base for a risk stratification tool directed at optimizing the accuracy of ED decisions: the Canadian Syncope Risk Score (CSRS). This tool is now ready for the final phase of its introduction into clinical practice, namely a robust, multicentre implementation trial of the CSRS-based practice reco |
| Who can participate | Physicians: Inclusion criteria: * ED physicians involved in ED syncope care * Non-ED physicians involved in ED syncope care * Physician's delegates involved in ED syncope care Exclusion criteria: * ED physicians not involved in ED syncope care * Non-ED physicians not involved in ED syncope care * Physician's delegates not involved in ED syncope care Patients: Inclusion criteria: * Patients who are adults (aged \> 18 years) * Patients who present to the ED within 24 hours of syncope. Exclusion criteria: * Patients who do not fulfill the definition of syncope, namely those with a prolonged loss of consciousness (i.e., \> 5 minutes), Glasgow Coma Scale \< 15 in patients without dementia (or a change in the mental status from baseline in those with dementia); * Patients with witnessed obvious |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Ottawa Hospital Research Institute |
| Locations | Calgary, Alberta, Canada; Winnipeg, Manitoba, Canada; Greater Sudbury, Ontario, Canada; Hawkesbury, Ontario, Canada; London, Ontario, Canada; North Bay, Ontario, Canada (+9 more sites) |
| Start date | 2023-09-18 |
| NCT ID | NCT04972071 |
| Official listing | https://clinicaltrials.gov/study/NCT04972071 |